Validic Secures $12.5M in Series B
2015-04-29
DURHAM, NC, Healthcare industry's leading digital health platform, announced today that it has secured a $12.5 million Series B round led by Kaiser Permanente Ventures.
Validic, the healthcare industry's leading digital health platform, announced today that it has secured a $12.5 million Series B round led by Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente. The funding will continue to fuel Validic's rapid growth.
Since launching Validic in 2010, the company has grown its client population reach to over 160 million lives in 47 countries and now integrates with over 175 fitness and clinical devices and applications. Validic continues to add clients within a variety of healthcare segments powering their patient data integration, including pharma, providers, insurance companies, wellness and healthcare technology companies. Two of those leading healthcare technology companies include Cerner and MEDITECH, both of which are utilizing the Validic platform to integrate mobile health and in-home clinical device data into patient portals.
'Kaiser Permanente Ventures is committed to partnering with entrepreneurs to advance clinical quality, service and affordability,' Jordan Kramer, Director Kaiser Permanente Ventures, stated. 'Leveraging technology to engage consumers and transform healthcare is a key priority for us. Validic fits well with that strategy.'
'We are honored to announce our recent Series B raise led by Kaiser Permanente Ventures,' Ryan Beckland, CEO and co-founder of Validic, said. 'With millions of individuals now using wearables, applications and clinical in-home devices to track and manage their health, it is more important now than ever that this data is accessible to healthcare providers. We have built an enterprise digital health platform to power this integration for healthcare companies allowing them to focus on driving their core technologies and programs, which are going to be vital to the future success of healthcare. With this investment, we will continue to build out our team and product offerings to fuel the utilization of digital health data to transform healthcare.'
Validic's mission is to empower healthcare and technology innovators. With access to secure and verified patient-generated data, leveraging Validic's solutions, healthcare organizations are better able to tackle patient engagement, population management, predictive analytics, improved outcomes, care coordination and cost-reducing initiatives.
About Validic
Validic is the healthcare industry's leading cloud-based, digital health platform for convenient and quick access to patient data from in-home clinical devices, wearables and patient healthcare applications. By connecting its growing base of customers -- that includes providers, pharmaceutical companies, payers, wellness companies and health IT vendors -- to the continuously expanding list of digital health technologies, Validic enables healthcare companies to better coordinate care across their communities, improve their patient engagement strategies and more efficiently manage their patient populations. Validic's innovative, scalable and FDA Class I MDDS technology delivers actionable, standardized and HIPAA-compliant consumer health data from the best in-class mobile health devices and applications. Validic was recognized for healthcare innovation by Gartner and received Frost & Sullivan's Best Practices and Best Value in Healthcare Information Interoperability award. Validic's leading global mobile health ecosystem reaches over 160 million lives and continues to grow daily. To learn more about Validic, follow Validic on Twitter at @validic or visit www.validic.com.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors